Free Trial

Pasithea Therapeutics (KTTA) SEC Filings & 10K Form

Pasithea Therapeutics logo
$1.34 +0.02 (+1.52%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$1.34 +0.00 (+0.37%)
As of 03/28/2025 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Pasithea Therapeutics SEC Filings

DateFilerForm TypeView
03/24/2025
3:55 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2025
8:55 PM
Pasithea Therapeutics (Subject)
Pasithea Therapeutics Corp. (Subject)
STEINMAN LAWRENCE (Filed by)
Form SCHEDULE 13D/A
02/14/2025
4:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
Pasithea Therapeutics (Subject)
Pasithea Therapeutics Corp. (Subject)
Form SCHEDULE 13G/A
11/26/2024
4:00 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:01 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 424B5
11/13/2024
3:30 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/14/2024
11:15 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form EFFECT
10/11/2024
4:12 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 424B3
09/30/2024
3:49 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
7:45 AM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
4:00 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:25 PM
Novak Alfred J (Reporting)
Pasithea Therapeutics (Issuer)
Pasithea Therapeutics Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:00 AM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form DEF 14A
05/28/2024
8:05 AM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form ARS
05/14/2024
4:15 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
8:45 PM
Pasithea Therapeutics (Issuer)
Pasithea Therapeutics Corp. (Issuer)
STEINMAN LAWRENCE (Reporting)
Form 4/A
04/05/2024
8:45 PM
Currie Graeme Martin (Reporting)
Pasithea Therapeutics (Issuer)
Pasithea Therapeutics Corp. (Issuer)
Form 4/A
04/05/2024
8:45 PM
Novak Alfred J (Reporting)
Pasithea Therapeutics (Issuer)
Pasithea Therapeutics Corp. (Issuer)
Form 4/A
04/05/2024
8:45 PM
Leahy Emer (Reporting)
Pasithea Therapeutics (Issuer)
Pasithea Therapeutics Corp. (Issuer)
Form 4/A
04/05/2024
8:45 PM
Pasithea Therapeutics (Issuer)
Pasithea Therapeutics Corp. (Issuer)
Schneiderman Daniel H (Reporting)
Form 4/A
04/05/2024
8:45 PM
Dumesnil Simon (Reporting)
Pasithea Therapeutics (Issuer)
Pasithea Therapeutics Corp. (Issuer)
Form 4/A
04/05/2024
8:45 PM
Marques Tiago (Reporting)
Pasithea Therapeutics (Issuer)
Pasithea Therapeutics Corp. (Issuer)
Form 4/A
04/02/2024
11:15 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:KTTA) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners